BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22371070)

  • 1. Common MUTYH mutations and colorectal cancer risk in multiethnic populations.
    Lejbkowicz F; Cohen I; Barnett-Griness O; Pinchev M; Poynter J; Gruber SB; Rennert G
    Fam Cancer; 2012 Sep; 11(3):329-35. PubMed ID: 22371070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
    Rosner G; Bercovich D; Daniel YE; Strul H; Fliss-Isakov N; Ben-Yehoiada M; Santo E; Halpern Z; Kariv R
    Fam Cancer; 2015 Sep; 14(3):427-36. PubMed ID: 25822476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MutYH mutation carriers have increased breast cancer risk.
    Rennert G; Lejbkowicz F; Cohen I; Pinchev M; Rennert HS; Barnett-Griness O
    Cancer; 2012 Apr; 118(8):1989-93. PubMed ID: 21952991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUTYH hotspot mutations in unselected colonoscopy patients.
    Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
    Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.
    Elsaid A; Elshazli R; El-Tarapely F; Darwish H; Abdel-Malak C
    Fam Cancer; 2017 Jan; 16(1):83-90. PubMed ID: 27631816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil.
    Pitroski CE; Cossio SL; Koehler-Santos P; Graudenz M; Prolla JC; Ashton-Prolla P
    Int J Colorectal Dis; 2011 Jul; 26(7):841-6. PubMed ID: 21424714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplifying the detection of MUTYH mutations by high resolution melting analysis.
    López-Villar I; Ayala R; Wesselink J; Morillas JD; López E; Marín JC; Díaz-Tasende J; González S; Robles L; Martínez-López J
    BMC Cancer; 2010 Aug; 10():408. PubMed ID: 20687945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.
    Theodoratou E; Campbell H; Tenesa A; Houlston R; Webb E; Lubbe S; Broderick P; Gallinger S; Croitoru EM; Jenkins MA; Win AK; Cleary SP; Koessler T; Pharoah PD; Küry S; Bézieau S; Buecher B; Ellis NA; Peterlongo P; Offit K; Aaltonen LA; Enholm S; Lindblom A; Zhou XL; Tomlinson IP; Moreno V; Blanco I; Capellà G; Barnetson R; Porteous ME; Dunlop MG; Farrington SM
    Br J Cancer; 2010 Dec; 103(12):1875-84. PubMed ID: 21063410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.
    Ukaegbu C; Levi Z; Fehlmann TD; Uno H; Chittenden A; Inra JA; Grover S; Kastrinos F; Syngal S; Yurgelun MB
    Fam Cancer; 2021 Apr; 20(2):111-116. PubMed ID: 32743790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer.
    Casper M; Acalovschi M; Lammert F; Zimmer V
    Fam Cancer; 2014 Jun; 13(2):243-7. PubMed ID: 24420788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis.
    Nielsen M; Joerink-van de Beld MC; Jones N; Vogt S; Tops CM; Vasen HF; Sampson JR; Aretz S; Hes FJ
    Gastroenterology; 2009 Feb; 136(2):471-6. PubMed ID: 19032956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review.
    Knopperts AP; Nielsen M; Niessen RC; Tops CM; Jorritsma B; Varkevisser J; Wijnen J; Siezen CL; Heine-Bröring RC; van Kranen HJ; Vos YJ; Westers H; Kampman E; Sijmons RH; Hes FJ
    Fam Cancer; 2013 Mar; 12(1):43-50. PubMed ID: 23007840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.
    Grover S; Kastrinos F; Steyerberg EW; Cook EF; Dewanwala A; Burbidge LA; Wenstrup RJ; Syngal S
    JAMA; 2012 Aug; 308(5):485-492. PubMed ID: 22851115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
    Yanus GA; Akhapkina TA; Ivantsov AO; Preobrazhenskaya EV; Aleksakhina SN; Bizin IV; Sokolenko AP; Mitiushkina NV; Kuligina ES; Suspitsin EN; Venina AR; Holmatov MM; Zaitseva OA; Yatsuk OS; Pashkov DV; Belyaev AM; Togo AV; Imyanitov EN; Iyevleva AG
    Clin Genet; 2018 May; 93(5):1015-1021. PubMed ID: 29406563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer.
    Win AK; Dowty JG; Cleary SP; Kim H; Buchanan DD; Young JP; Clendenning M; Rosty C; MacInnis RJ; Giles GG; Boussioutas A; Macrae FA; Parry S; Goldblatt J; Baron JA; Burnett T; Le Marchand L; Newcomb PA; Haile RW; Hopper JL; Cotterchio M; Gallinger S; Lindor NM; Tucker KM; Winship IM; Jenkins MA
    Gastroenterology; 2014 May; 146(5):1208-11.e1-5. PubMed ID: 24444654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
    Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
    Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
    Drucker L; Stackievitz R; Shpitz B; Yarkoni S
    Anticancer Res; 2000; 20(1B):559-61. PubMed ID: 10769725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
    Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
    Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort.
    Fulk K; LaDuca H; Black MH; Qian D; Tian Y; Yussuf A; Espenschied C; Jasperson K
    Fam Cancer; 2019 Apr; 18(2):197-201. PubMed ID: 30582135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Amouri A; Tahri N; Ayadi L; Khabir A; Frikha F; Gargouri A; Mokdad-Gargouri R
    Fam Cancer; 2012 Sep; 11(3):503-8. PubMed ID: 22744763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.